Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 2 | 2009 | 5 | 0.350 |
Why?
|
| Sternum | 1 | 2009 | 1 | 0.310 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2009 | 1 | 0.310 |
Why?
|
| Esophageal Neoplasms | 3 | 2011 | 10 | 0.240 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 50 | 0.230 |
Why?
|
| Adult | 8 | 2013 | 2113 | 0.140 |
Why?
|
| Male | 8 | 2013 | 3671 | 0.120 |
Why?
|
| Humans | 12 | 2013 | 6794 | 0.120 |
Why?
|
| Middle Aged | 8 | 2013 | 2108 | 0.110 |
Why?
|
| Esophagectomy | 2 | 2011 | 4 | 0.110 |
Why?
|
| Lymphatic Metastasis | 2 | 2011 | 8 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2010 | 23 | 0.100 |
Why?
|
| Bile Duct Diseases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2013 | 6 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 57 | 0.100 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2012 | 1 | 0.100 |
Why?
|
| Mitral Valve | 1 | 2012 | 4 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 7 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2012 | 5 | 0.090 |
Why?
|
| Calcinosis | 1 | 2012 | 12 | 0.090 |
Why?
|
| Female | 9 | 2013 | 4060 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 8 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 14 | 0.080 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 8 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2010 | 5 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 23 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 31 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 51 | 0.080 |
Why?
|
| Mastitis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Granuloma | 1 | 2009 | 6 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 10 | 0.080 |
Why?
|
| Colectomy | 1 | 2008 | 1 | 0.070 |
Why?
|
| Aged | 5 | 2013 | 1539 | 0.070 |
Why?
|
| Ulcer | 1 | 2008 | 3 | 0.070 |
Why?
|
| Rectal Diseases | 1 | 2008 | 3 | 0.070 |
Why?
|
| Dietary Fiber | 1 | 2008 | 9 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2008 | 6 | 0.070 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 6 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2008 | 38 | 0.070 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2005 | 1 | 0.060 |
Why?
|
| Hysterectomy | 1 | 2005 | 12 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 79 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 170 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2009 | 681 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2005 | 25 | 0.060 |
Why?
|
| Prognosis | 3 | 2010 | 220 | 0.050 |
Why?
|
| Muscle Neoplasms | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sarcoma | 1 | 2002 | 2 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2009 | 45 | 0.040 |
Why?
|
| Biopsy | 2 | 2012 | 36 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 64 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2010 | 42 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2010 | 10 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 24 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2005 | 12 | 0.030 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2013 | 1 | 0.020 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2013 | 1 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2013 | 2 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 26 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2012 | 2 | 0.020 |
Why?
|
| Multimodal Imaging | 1 | 2012 | 5 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 4 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 9 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 127 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 111 | 0.020 |
Why?
|
| Endostatins | 1 | 2010 | 1 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 5 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2010 | 13 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2010 | 2 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 30 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 104 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 17 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 5 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 5 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 7 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 13 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 170 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 128 | 0.020 |
Why?
|
| Defecography | 1 | 2008 | 1 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 32 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 497 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 2 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 4 | 0.020 |
Why?
|
| Mastectomy | 1 | 2008 | 5 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 72 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 98 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2008 | 31 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 567 | 0.020 |
Why?
|
| Algorithms | 1 | 2008 | 83 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2005 | 19 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 20 | 0.010 |
Why?
|
| Premenopause | 1 | 2005 | 6 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 56 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 869 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 118 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 95 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 108 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 169 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 268 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 197 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 500 | 0.010 |
Why?
|
| Mitosis | 1 | 2002 | 2 | 0.010 |
Why?
|
| Necrosis | 1 | 2002 | 30 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 38 | 0.010 |
Why?
|